James Siegler to Tissue Plasminogen Activator
This is a "connection" page, showing publications James Siegler has written about Tissue Plasminogen Activator.
Connection Strength
1.574
-
Intravenous Thrombolysis Attenuates Neurologic Deterioration After Ischemic Stroke. South Med J. 2016 10; 109(10):661-667.
Score: 0.507
-
Letter by Siegler and Martin-Schild regarding article, "Comparison of risk-scoring systems in predicting symptomatic intracerebral hemorrhage after intravenous thrombolysis". Stroke. 2013 Aug; 44(8):e97.
Score: 0.405
-
Author Response: Endovascular vs Medical Management for Late Anterior Large Vessel Occlusion With Prestroke Disability: Analysis of CLEAR and RESCUE-Japan. Neurology. 2023 03 28; 100(13):642.
Score: 0.199
-
Reexpression of Prior Stroke Symptoms in Adults: When is a Mimic a Mimic? Neurologist. 2017 Sep; 22(5):199-203.
Score: 0.135
-
Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis. J Stroke Cerebrovasc Dis. 2016 Nov; 25(11):2603-2609.
Score: 0.125
-
Trimming the fat in acute ischemic stroke: an assessment of 24-h CT scans in tPA patients. Int J Stroke. 2015 Jan; 10(1):37-41.
Score: 0.108
-
Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic: The Society of Vascular and Interventional Neurology Multicenter Collaboration. Clin Neurol Neurosurg. 2021 02; 201:106436.
Score: 0.042
-
Persistent leukocytosis-is this a persistent problem for patients with acute ischemic stroke? J Stroke Cerebrovasc Dis. 2014 Aug; 23(7):1939-43.
Score: 0.027
-
Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):e255-61.
Score: 0.026